what is glp-1 micro dosing People Are Microdosing Weight-Loss Drugs Such as Ozempic and Wegovy. Here's Why What is GLP-1 Microdosing, and

Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around obesity treatment drive troves of patients some studies estimate roughly half or more to stop GLP-1s within a year and risk regaining the weight they lost

An Australian study warns that some patients on GLP-1 medications may face nutrient deficiencies, prompting experts to share guidance on safe use, prevention, and best practices.

We are proud to share that Professor Jens Juul Holst from the Department of Biomedical Sciences has been awarded the Lipid Science Prize 2026 by the Camurus Lipid Research Foundation in Malm. Jens receives the prize in recognition of his groundbreaking discovery of the GLP1 hormone back in 1986 - a finding that laid the foundation for diabetes and weightloss medications used by millions worldwide

Descubre cunto tiempo debe continuar el tratamiento con agonistas GLP-1, qu factores determinan su duracin y qu alternativas existen para el manejo a largo plazo de diabetes y obesidad.

Current management strategies include optimising blood glucose control, dietary modifications and supportive nutrition

No account required.